PELTHOS THERAPEUTICS INC (PTHS) Stock Price, Quote, News and Overview
NYSEARCA:PTHS - NYSE Arca - US1711262048 - Common Stock - Currency: USD
PTHS Quote, Performance and Key Statistics
19.04
-0.89 (-4.47%)
The current stock price of PTHS is 19.04 USD. In the past month the price increased by 3.93%.
PTHS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.7 | 349.84B | ||
| AMGN | AMGEN INC | 13.22 | 154.98B | ||
| GILD | GILEAD SCIENCES INC | 15.43 | 148.54B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 21.64 | 94.13B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.34 | 60.79B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 57.23B | ||
| ARGX | ARGENX SE - ADR | 71.39 | 40.50B | ||
| ONC | BEONE MEDICINES LTD-ADR | 4.5 | 31.19B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.84B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 21.28B | ||
| INSM | INSMED INC | N/A | 20.78B | ||
| NTRA | NATERA INC | N/A | 20.75B |
Related stock screener links
About PTHS
Company Profile
Pelthos Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in North Brunswick, New Jersey and currently employs 4 full-time employees. The company went IPO on 2024-02-16. Pelthos Therapeutics Inc., formerly Channel Therapeutics Corporation, is a biopharmaceutical company focused on commercializing therapeutic products for high unmet patient needs. The firm's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. ZELSUVMI is an FDA-designated novel drug, and a prescription medication approved for the treatment of molluscum that can be administered at home by parents, patients, and caregivers. The firm is also evaluating the path forward for its existing NaV 1.7 development programs for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks.
Company Info
PELTHOS THERAPEUTICS INC
685 Us Highway One
North Brunswick NEW JERSEY US
Employees: 4
Phone: 19176446313
PELTHOS THERAPEUTICS INC / PTHS FAQ
What is the stock price of PELTHOS THERAPEUTICS INC today?
The current stock price of PTHS is 19.04 USD. The price decreased by -4.47% in the last trading session.
What is the ticker symbol for PELTHOS THERAPEUTICS INC stock?
The exchange symbol of PELTHOS THERAPEUTICS INC is PTHS and it is listed on the NYSE Arca exchange.
On which exchange is PTHS stock listed?
PTHS stock is listed on the NYSE Arca exchange.
What is PELTHOS THERAPEUTICS INC worth?
PELTHOS THERAPEUTICS INC (PTHS) has a market capitalization of 57.69M USD. This makes PTHS a Micro Cap stock.
How many employees does PELTHOS THERAPEUTICS INC have?
PELTHOS THERAPEUTICS INC (PTHS) currently has 4 employees.
What are the support and resistance levels for PELTHOS THERAPEUTICS INC (PTHS) stock?
PELTHOS THERAPEUTICS INC (PTHS) has a resistance level at 20.89. Check the full technical report for a detailed analysis of PTHS support and resistance levels.
Should I buy PELTHOS THERAPEUTICS INC (PTHS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PTHS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PTHS, evaluating the profitability, health, valuation and growth aspects
- PELTHOS THERAPEUTICS INC (PTHS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PELTHOS THERAPEUTICS INC (PTHS) Sales and EPS estimates to see what analysts future expectations are.
- PELTHOS THERAPEUTICS INC (PTHS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PELTHOS THERAPEUTICS INC (PTHS) Insider and Institutional Ownership to learn about the owners and their transactions.
- PELTHOS THERAPEUTICS INC (PTHS) Stock Chart to make your own analysis
- PELTHOS THERAPEUTICS INC (PTHS) Latest news and press-releases to stay up to date.
Does PELTHOS THERAPEUTICS INC (PTHS) stock pay dividends?
PTHS does not pay a dividend.
What is the Price/Earnings (PE) ratio of PELTHOS THERAPEUTICS INC (PTHS)?
PELTHOS THERAPEUTICS INC (PTHS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.28).
PTHS Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to PTHS.
PTHS Financial Highlights
Over the last trailing twelve months PTHS reported a non-GAAP Earnings per Share(EPS) of -1.28. The EPS decreased by -197.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -810.01% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PTHS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PTHS. The Buy consensus is the average rating of analysts ratings from 7 analysts.